Xencor Inc XNCR
- XmAb808 — Solid Tumors Phase 1
- JNJ-9401 — Metastatic Castration-Resistant Prostate Cancer Phase 1
- JNJ-1493 — B-Cell Lymphoma Phase 1
CD28 (1 companies · 3 programs)
Companies with an active program directed at CD28.
Companies with an active program directed at CD28.